ERBB2 and breast cancer: Within the TME, we have previously identified the ability of joint stimulation by estrogen, tumor necrosis factor α (TNFα) and epithelial growth factor (EGF) to profoundly elevate the content of CSCs in HR+/HER2− breast cancer cells [16].